Spain - Healthcare, Regulatory and Reimbursement Landscape

Spain - Healthcare, Regulatory and Reimbursement Landscape

  • September 2021 •
  • 173 pages •
  • Report ID: 6134056 •
  • Format: PDF
Spain - Healthcare, Regulatory and Reimbursement Landscape

The analyst has released its latest report, "Spain - Healthcare, Regulatory and Reimbursement Landscape".The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Spain.

It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure.Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

The Spanish pharmaceutical market is one of the major markets of the EU Region. The market value, in terms of Euros, increased from €10.7B in 2013 to €20.5B in 2020 at a Compound Annual Growth Rate (CAGR) of 8%. In terms of US dollars, the market increased from $10.7B in 2013 to $23.4B in 2020 at a CAGR of 6.4%. The medical devices market of Spain was $7.71B in 2017, which increased at a CAGR of 5% to reach $8.93B in 2020. The market is expected to grow at a CAGR of 1.2% from $9.35B in 2021 to reach $9.83B in 2025. Universal healthcare coverage, high pharmaceutical exports, and a strong clinical research environment are some of the factors driving the market. However, the introduction of a new action plan in 2020 by the Ministry of Health to promote the use of generic drugs may impede market growth.

The report provides information on the healthcare, regulatory, and reimbursement landscape in Spain, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Almirall, Bayer, Boehringer Ingelheim, Grifols, and Merck KGaA.
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Alcon, GE Healthcare, Fresenius, and Roche Diagnostics
- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement landscape, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Spanish healthcare market

Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Spanish healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Spanish healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.